Competing interests
CORONAVIRUS
N.M.O., L.R., Y.A., B.S., E.G.M., and P.P. are employees of PT. PT received funding for the Phase 1 trial from National Research Council of Canada. N.V., A.M., and T.A. work at Manna Research, the Contract Research Organization that performed the clinical trial. A-C.G., R.S., and Q.H. declare no potential conflict of interest. The development of the B.1.617.2 (Delta) lentiviral assay was supported by the CIHR operating grant to the Coronavirus Variants Rapid Response Network (CoVaRR-Net) to A-C.G. A-C.G. is the Canada Research Chair, Tier 1, in Functional Proteomics. All other authors have no competing interests.